Scinai Immunotherapeutics (SCNI) Net Income Growth (1y) (2015 - 2024)
Scinai Immunotherapeutics (SCNI) Net Income Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.34% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -43.69% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -73.01% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -290.15% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -230.18% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 59.59% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -24.14% |
| Sep 30, 2024 | 249.83% |
| Jun 30, 2024 | -326.71% |
| Mar 31, 2024 | -39.49% |
| Dec 31, 2023 | 90.46% |
| Sep 30, 2023 | -1,755.58% |
| Jun 30, 2023 | -62.42% |
| Mar 31, 2023 | 269.65% |
| Dec 31, 2022 | -221.30% |
| Sep 30, 2022 | 92.74% |
| Jun 30, 2022 | 218.83% |
| Mar 31, 2022 | -51.21% |
| Dec 31, 2021 | 238.61% |
| Sep 30, 2021 | -109.70% |
| Mar 31, 2021 | 93.76% |
| Sep 30, 2020 | 405.05% |
| Mar 31, 2020 | -287.03% |
| Sep 30, 2019 | -1,401.80% |
| Jun 30, 2019 | 138.12% |
| Mar 31, 2019 | -63.50% |